vs
HCI Group, Inc.（HCI）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是HCI Group, Inc.的1.6倍（$382.2M vs $246.2M），HCI Group, Inc.净利率更高（39.7% vs 3.1%，领先36.6%），HCI Group, Inc.同比增速更快（52.1% vs 17.4%），HCI Group, Inc.自由现金流更多（$440.8M vs $46.6M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 9.2%）
HCI集团是一家总部位于美国华盛顿特区的私募股权投资公司，在伊利诺伊州芝加哥设有分支机构，专注于股权投资相关业务，为合作企业提供资本支持与运营赋能，助力企业实现长期发展目标。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
HCI vs LFST — 直观对比
营收规模更大
LFST
是对方的1.6倍
$246.2M
营收增速更快
HCI
高出34.7%
17.4%
净利率更高
HCI
高出36.6%
3.1%
自由现金流更多
HCI
多$394.2M
$46.6M
两年增速更快
LFST
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $246.2M | $382.2M |
| 净利润 | $97.7M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | 58.5% | 4.7% |
| 净利率 | 39.7% | 3.1% |
| 营收同比 | 52.1% | 17.4% |
| 净利润同比 | 3679.2% | 264.1% |
| 每股收益（稀释后） | $7.29 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCILFST
| Q4 25 | $246.2M | $382.2M | ||
| Q3 25 | $216.3M | $363.8M | ||
| Q2 25 | $221.9M | $345.3M | ||
| Q1 25 | $216.4M | $333.0M | ||
| Q4 24 | $161.9M | $325.5M | ||
| Q3 24 | $175.3M | $312.7M | ||
| Q2 24 | $206.2M | $312.3M | ||
| Q1 24 | $206.6M | $300.4M |
净利润HCILFST
| Q4 25 | $97.7M | $11.7M | ||
| Q3 25 | $65.5M | $1.1M | ||
| Q2 25 | $66.2M | $-3.8M | ||
| Q1 25 | $69.7M | $709.0K | ||
| Q4 24 | $2.6M | $-7.1M | ||
| Q3 24 | $5.7M | $-6.0M | ||
| Q2 24 | $54.1M | $-23.3M | ||
| Q1 24 | $47.6M | $-21.1M |
营业利润率HCILFST
| Q4 25 | 58.5% | 4.7% | ||
| Q3 25 | 41.9% | 2.0% | ||
| Q2 25 | 42.5% | -0.9% | ||
| Q1 25 | 46.4% | 0.5% | ||
| Q4 24 | 3.6% | 0.3% | ||
| Q3 24 | 8.0% | 0.0% | ||
| Q2 24 | 36.9% | -5.1% | ||
| Q1 24 | 37.5% | -5.6% |
净利率HCILFST
| Q4 25 | 39.7% | 3.1% | ||
| Q3 25 | 30.3% | 0.3% | ||
| Q2 25 | 29.8% | -1.1% | ||
| Q1 25 | 32.2% | 0.2% | ||
| Q4 24 | 1.6% | -2.2% | ||
| Q3 24 | 3.2% | -1.9% | ||
| Q2 24 | 26.2% | -7.5% | ||
| Q1 24 | 23.0% | -7.0% |
每股收益（稀释后）HCILFST
| Q4 25 | $7.29 | — | ||
| Q3 25 | $4.90 | — | ||
| Q2 25 | $5.18 | — | ||
| Q1 25 | $5.35 | — | ||
| Q4 24 | $0.32 | — | ||
| Q3 24 | $0.52 | — | ||
| Q2 24 | $4.24 | — | ||
| Q1 24 | $3.81 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $1.0B | $1.5B |
| 总资产 | $2.5B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资HCILFST
| Q4 25 | $1.2B | $248.6M | ||
| Q3 25 | $987.9M | $203.9M | ||
| Q2 25 | $947.2M | $188.9M | ||
| Q1 25 | $754.5M | $134.3M | ||
| Q4 24 | $532.5M | $154.6M | ||
| Q3 24 | $518.8M | $102.6M | ||
| Q2 24 | $445.8M | $87.0M | ||
| Q1 24 | $655.4M | $49.5M |
总债务HCILFST
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
股东权益HCILFST
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $821.8M | $1.5B | ||
| Q2 25 | $758.6M | $1.5B | ||
| Q1 25 | $522.7M | $1.5B | ||
| Q4 24 | $453.3M | $1.4B | ||
| Q3 24 | $455.3M | $1.4B | ||
| Q2 24 | $447.3M | $1.4B | ||
| Q1 24 | $395.7M | $1.4B |
总资产HCILFST
| Q4 25 | $2.5B | $2.2B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.4B | $2.1B | ||
| Q1 25 | $2.3B | $2.1B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.1B | ||
| Q1 24 | $1.8B | $2.1B |
负债/权益比HCILFST
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $444.4M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $440.8M | $46.6M |
| 自由现金流率自由现金流/营收 | 179.0% | 12.2% |
| 资本支出强度资本支出/营收 | 1.5% | 2.9% |
| 现金转化率经营现金流/净利润 | 4.55× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $771.4M | $110.0M |
8季度趋势，按日历期对齐
经营现金流HCILFST
| Q4 25 | $444.4M | $57.6M | ||
| Q3 25 | $26.7M | $27.3M | ||
| Q2 25 | $145.0M | $64.4M | ||
| Q1 25 | $162.0M | $-3.1M | ||
| Q4 24 | $331.8M | $62.3M | ||
| Q3 24 | $104.1M | $22.7M | ||
| Q2 24 | $-29.0M | $44.1M | ||
| Q1 24 | $182.0M | $-21.8M |
自由现金流HCILFST
| Q4 25 | $440.8M | $46.6M | ||
| Q3 25 | $25.9M | $17.0M | ||
| Q2 25 | $144.5M | $56.6M | ||
| Q1 25 | $160.3M | $-10.3M | ||
| Q4 24 | $327.8M | $56.0M | ||
| Q3 24 | $103.2M | $17.7M | ||
| Q2 24 | $-30.1M | $39.0M | ||
| Q1 24 | $181.0M | $-26.9M |
自由现金流率HCILFST
| Q4 25 | 179.0% | 12.2% | ||
| Q3 25 | 12.0% | 4.7% | ||
| Q2 25 | 65.1% | 16.4% | ||
| Q1 25 | 74.1% | -3.1% | ||
| Q4 24 | 202.5% | 17.2% | ||
| Q3 24 | 58.9% | 5.7% | ||
| Q2 24 | -14.6% | 12.5% | ||
| Q1 24 | 87.6% | -9.0% |
资本支出强度HCILFST
| Q4 25 | 1.5% | 2.9% | ||
| Q3 25 | 0.4% | 2.8% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | 0.8% | 2.2% | ||
| Q4 24 | 2.5% | 1.9% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.5% | 1.6% | ||
| Q1 24 | 0.5% | 1.7% |
现金转化率HCILFST
| Q4 25 | 4.55× | 4.93× | ||
| Q3 25 | 0.41× | 25.34× | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 2.32× | -4.36× | ||
| Q4 24 | 128.41× | — | ||
| Q3 24 | 18.33× | — | ||
| Q2 24 | -0.54× | — | ||
| Q1 24 | 3.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCI
| Insurance Operation | $218.3M | 89% |
| Reciprocal Exchange Operation | $27.0M | 11% |
LFST
暂无分部数据
